JA Kovacs, L Deyton, R Davey, J Falloon, K … - Annals of Internal Medicine, 1989 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Study Objective: To evaluate the toxicity and potential clinical efficacy ... Cited by 104 - Related articles - All 2 versions
SE Krown, JWM Gold, D Niedzwiecki, D … - Annals of Internal Medicine, 1990 - Am Coll Physicians Objective: To evaluate safety, tolerance, and potential efficacy of
interferon-α and zidovudine combination therapy in patients with Kaposi sarcoma
and the acquired immunodeficiency syndrome (AIDS). Cited by 129 - Related articles - All 4 versions
HC Lane, J Feinberg, V Davey, L Deyton, M … - Lancet(British edition), 1988 - cat.inist.fr Anti-retroviral effects of interferon-α in AIDS associated Kaposi's sarcoma.
HC LANE, J FEINBERG, V DAVEY, L DEYTON, M BASELER, J ... Cited by 157 - Related articles - All 4 versions
MA Fischl, RB Uttamchandani, L Resnick, R … - JAIDS Journal of Acquired Immune Deficiency …, 1991 - journals.lww.com Summary: To determine the safety, maximum tolerated dose, and preliminary
efficacy of concomitant interferon-[alpha] and zidovudine therapy in
AIDS-related Kaposi's sarcoma (KS), 56 patients with biopsy-proven KS ... Cited by 39 - Related articles - All 4 versions
- ►nih.gov [PDF] KL Hartshorn, MW Vogt, TC Chou, RS … - Antimicrobial agents and chemotherapy, 1987 - Am Soc Microbiol KEVAN L. HARTSHORN,' MARKUS W. VOGT,' TING-CHAO CHOU,2 RICHARD S. BLUMBERG,' ROY
BYINGTON,' ROBERT T. SCHOOLEY,' AND MARTIN S. HIRSCH'* ... Infectious Disease
Unit, Massachusetts General Hospital, Harvard Medical School, Cited by 180 - Related articles - All 7 versions
R De Wit, CAB Boucher, KHN Veenhof, J … - Lancet(British edition), 1988 - cat.inist.fr Clinical and virological effects of high-dose recombinant interferon-α in
disseminated AIDS-related Kaposi's sarcoma. R DE WIT, CAB ... Cited by 124 - Related articles - All 3 versions
HC Lane, J Falloon, RE Walker, L Deyton, JA … - Annals of internal medicine, 1989 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Study Objective: To evaluate the toxicity, effects on immune function, ... Cited by 52 - Related articles - All 4 versions
DD Ho, KL Hartshorn, TR Rota, CA Andrews, … - Lancet, 1985 - ncbi.nlm.nih.gov Recombinant human interferon alfa-A (rIFN alpha A) had a dose-related
suppressive effect on human T lymphotropic virus type III (HTLV-III) replication
in vitro in normal peripheral-blood mononuclear cells (PBMC). Both ... Cited by 189 - Related articles - All 4 versions
RT Davey Jr, VJ Davey, JA Metcalf, JJ Zurlo, … - The Journal of infectious diseases, 1991 - jstor.org A Phase I/II Trial of Zidovudine, Interferon-a, and Granulocyte-Macrophage ...
Colony-Stimulating Factor in the Treatment of Human ... Richard T. Davey, Jr.,
Victoria J. Davey, Julia A. Metcalf, John J. Zurlo, Joseph A. Kovacs, ... Cited by 39 - Related articles - All 4 versions
EP Gelmann, OT Preble, R Steis, HC Lane, AH … - The American journal of medicine, 1985 - Elsevier Thirty consecutive patients with the acquired immune deficiency syndrome were
treated with intramuscular human lymphoblastoid interferon for Kaposi's sarcoma.
Patients were divided Into three groups receiving 7.5 million units/m 2 per ... Cited by 66 - Related articles - All 3 versions
